- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
March 10, 2023Robins Kaplan Announces $28 Million Settlement in Case Against For-Profit College’s Directors & Officers
March 9, 2023Robins Kaplan LLP Launches New Professional Development Program
March 19-22, 2023PLRB 2023 Claims Conference
March 29-30, 2023ACI Managed Care Disputes and Litigation
April 3, 2023Conference of Tribal Lending Commissioners
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
February 22, 2023A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
February 7, 2023When Monkey Business Slips Into Trademark Infringement
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Robins Kaplan Attorneys Nominated for Antitrust Writing Awards 2021
May 7, 2021
Robins Kaplan attorneys Matthew Geyer, William Reiss, and Benjamin Steinberg have been nominated for Concurrences’ 2021 Antitrust Writing Awards.
Concurrences will select the winners based on votes received from readers, as well as the opinions of its handpicked jury. You can read the nominated articles and cast your votes for them at the links below. The articles are:
No-Poach Antitrust Standard Unclear In Franchising
By Matthew Geyer and William Reiss
October 22, 2020
Geyer and Reiss’s article was nominated in the Concerted Practices subcategory of the Business category. Published in Law360, this article explores the divergent approaches to analyzing no-poach agreements under the antitrust laws, and assesses the strategies plaintiffs and defendants are likely to employ in attempting to navigate ambiguities in the law. Read the full article and cast your vote here.
States Can Use the Coronavirus Response to Go After Insulin Price Gougers
By Benjamin Steinberg
April 9, 2020
Steinberg’s article was nominated in the Unilateral Conduct subcategory of the Business category. Published in Slate, this piece explores the COVID-19 healthcare crisis beyond the virus, including the loss of employer-provided health insurance. Without insurance, the costs of life-saving drugs can skyrocket. Insulin alone can cost $12,000 a year. So what can be done to keep insulin affordable during the crisis? One solution might come from a novel legal strategy that would test the limits of what constitutes illegal price gouging. Read the full article and cast your vote here.
Finalists for the awards will be chosen by Concurrences, and a winner for each category will be announced at a virtual awards ceremony on June 30.
Matthew J. Geyer
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.